Streetbeat News

ZIVO

Zivo Bioscience Inc

https://zivobioscience.com/

CEO

Andrew Dahl

Employees

Industry

Biological Product (except Diagnostic) Manufacturing

zivo bioscience, inc., a u.s.-based r&d firm, is dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from proprietary algal strains.

Open

20.90

Mkt cap

74M

Volume

723

High

21.00

P/E Ratio

-4.35

52-wk high

22.15

Low

20.90

Div yield

N/A

52-wk low

0.48

Maxim Group analyst Anthony Vendetti has downgraded Zivo Bioscience from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

June 04, 2024 | 3:28 pm

In Thursday's intraday session, several consumer staples stocks experienced significant movements. Safety Shot (SHOT) saw a 21.5% increase, while Oatly Group (OTLY) rose by 18.61%. Zivo Bioscience (ZIVO) increased by 16.42% following its Q3 earnings report 3 days ago. Chanson International (CHSN) and Webuy Global (WBUY) also saw gains of 15.72% and 15.36%, respectively. Paranovus Enter (PAVS) stock went up by 11.91%. On the losing side, Sadot Group (SDOT) dropped by 14.6% after its Q3 earnings 2 days ago, Ispire Technology (ISPR) fell by 13.11% post Q1 earnings, 22nd Century Group (XXII) declined by 11.24%, Benson Hill (BHIL) decreased by 10.35%, and Bit Brother (BETS) fell by 9.64%.

Portfolio Pulse from Benzinga Insights

November 16, 2023 | 5:31 pm

Insider trading has been observed in four US-listed companies: ZIVO Bioscience, Keurig Dr Pepper, Sound Financial Bancorp, and OceanFirst Financial. ZIVO Bioscience's 10% owner, Strome Group Inc, acquired 366,286 shares at an average price of $7.67, costing around $2.81 million. Keurig Dr Pepper's Chief R&D Officer, Karin Rotem-Wildeman, acquired 7,050 shares at an average price of $29.95. Sound Financial Bancorp's 10% owner, Stilwell Partners LP, bought 4,470 shares at an average price of $35.78. OceanFirst Financial's Anthony Giordano III bought 2,345 shares at an average price of $12.75.

Portfolio Pulse from Lisa Levin

October 31, 2023 | 10:35 am

ZIVO Bioscience, Inc. (NASDAQ:ZIVO) has initiated a 42-day study to validate the efficacy of its immune-modulating treatment for coccidiosis in broiler chickens. The product is designed to boost immune response, allowing birds to combat the disease without the use of antimicrobial compounds. The study aims to confirm the positive effects of ZIVO's non-antibiotic alternative, including reduced mortality and reduction in the incidence and severity of intestinal lesions. The results are expected by the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 12:35 pm

Zivo Bioscience, Inc. (NASDAQ:ZIVO) has announced a 1-for-6 reverse stock split, effective at 5:00 p.m. ET on October 26, 2023. The reverse split will reduce the number of authorized shares from 150,000,000 to 25,000,000, with each stockholder's ownership percentage remaining unchanged. The move is part of Zivo's plan to regain compliance with Nasdaq's continued listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 26, 2023 | 12:37 pm

Several consumer staples stocks experienced significant movement in Thursday's after-market session. Notable gainers included Splash Beverage Group (SBEV), Bruush Oral Care (BRSH), Alkaline Water Co (WTER), Safety Shot (SHOT), Shineco (SISI), and Zivo Bioscience (ZIVO). On the other hand, AgriFORCE Growing Systems (AGRI), Better Choice Co (BTTR), Sadot Group (SDOT), Meiwu Technology Co (WNW), Davis Commodities (DTCK), and Honest Co (HNST) saw their stock prices decline.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 9:32 pm

During Thursday's intraday session, several consumer staples stocks experienced significant movement. Meiwu Technology Co (NASDAQ:WNW), Better Choice Co (AMEX:BTTR), Planet Green Holdings (AMEX:PLAG), Davis Commodities (NASDAQ:DTCK), Splash Beverage Group (AMEX:SBEV), and Lamb Weston Hldgs (NYSE:LW) saw their stocks rise, with Meiwu Technology Co leading the gainers with a 45.1% increase. On the other hand, Zivo Bioscience (NASDAQ:ZIVO), Alkaline Water Co (NASDAQ:WTER), Safety Shot (NASDAQ:SHOT), Cyanotech (NASDAQ:CYAN), and Missfresh (NASDAQ:MF) experienced declines, with Zivo Bioscience leading the losers with a 22.5% decrease.

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 5:31 pm

Several stocks experienced significant movement in Thursday's mid-day session. Orchard Therapeutics plc (ORTX) shares climbed 97.7% after agreeing to be acquired by Japan's Kyowa Kirin. SP Plus Corporation (SP) shares gained 47.5% after Metropolis Technologies announced it will acquire the company. Accolade Inc (ACCD) shares fell 9.9% after the company reported second-quarter results. Grupo Aeroportuario del Centro Norte (OMAB) shares dipped 39.6%.

Portfolio Pulse from Lisa Levin

October 05, 2023 | 5:23 pm

Zivo Bioscience has announced the results of a month-long coccidiosis trial in broiler chickens. The company stated that all test groups demonstrated a statistically significant benefit in broiler health under simulated commercial conditions.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:17 pm

Zivo Bioscience, Inc. (NASDAQ:ZIVO) announced that ZWorldwide, an independent distributor with exclusive rights to the Zivolife product in North America, will purchase the entire supply of Zivolife produced for the first 18 months. ZWorldwide has also committed to purchasing at least 24,000 kilograms of product for each of the next five years. ZIVO is working with Alimenta Algae to increase production volumes and expects to have significantly expanded production capacity fully operational in 2025.

Portfolio Pulse from Happy Mohamed

August 16, 2023 | 12:34 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.